Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57,709,383
-
Total 13F shares
-
51,276,608
-
Share change
-
+1,539,253
-
Total reported value
-
$2,344,528,500
-
Put/Call ratio
-
142%
-
Price per share
-
$45.80
-
Number of holders
-
308
-
Value change
-
+$80,955,651
-
Number of buys
-
157
-
Number of sells
-
146
Institutional Holders of SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) as of Q1 2018
As of 31 Mar 2018,
SUPERNUS PHARMACEUTICALS, INC. - Common Stock (SUPN) was held by
308 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
51,276,608 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, Invesco Ltd., Bank of New York Mellon Corp, STATE STREET CORP, DIMENSIONAL FUND ADVISORS LP, RICE HALL JAMES & ASSOCIATES, LLC, Champlain Investment Partners, LLC, ACADIAN ASSET MANAGEMENT LLC, and ROTHSCHILD ASSET MANAGEMENT INC.
This page lists
308
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.